Advocacy intelligence hub — real-time data for patient organizations
Beacon Therapeutics — PHASE1, PHASE2
Beacon Therapeutics — PHASE1, PHASE2
STZ eyetrial — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
NAGLAZYME
BioMarin Pharmaceutical Inc.
David Jacobs, MD, MBA
Applied Genetics Technologies Corporation
Brian P Brooks, M.D.
National Eye Institute (NEI)
📍 Bethesda, Maryland
James Bainbridge, M.D
Chief Investigator
📍 GREENWOOD VILLAGE, CO
James Bainbridge, Prof, M.D
Chief Investigator
📍 GREENWOOD VILLAGE, CO
Dominik Fischer, Prof.
University Hospital Tuebingen, Center for Ophthalmology
Yin Shen
Renmin Hospital of Wuhan University